tiprankstipranks
Evolus, Inc. (EOLS)
NASDAQ:EOLS
US Market
Want to see EOLS full AI Analyst Report?

Evolus (EOLS) Earnings Dates, Call Summary & Reports

574 Followers

Earnings Data

Report Date
Aug 05, 2026
Before Open (Confirmed)
Period Ending
2026 (Q2)
Consensus EPS Forecast
-0.04
Last Year’s EPS
-0.25
Same Quarter Last Year
Based on 5 Analysts Ratings

Earnings Call Summary

Q1 2026
Earnings Call Date:May 04, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call presented a broadly constructive picture: revenue growth (Q1 +7%), healthy margins (adjusted gross margin 68%), expanding commercial footprint and loyalty (Rewards members +27% YoY), and a return to positive adjusted EBITDA ($0.6M) alongside reiterated full-year guidance and planned product launches (Esteem in Europe, Sculp FDA in Q4). Key risks include timing/seasonality comparatives, a newly announced 15% South Korea tariff on certain products, a still-small contribution from Evolisse amid a soft filler market, and continued competitive entrants. On balance, the operational improvements, profitability momentum, and clear pipeline/launch cadence outweigh the cited headwinds.
Company Guidance
The company reiterated full-year 2026 guidance of total net revenue of $327 million to $337 million (implying total company revenue growth of 10%–13%), adjusted gross margin of 65.5%–67%, non‑GAAP operating expenses of $210 million to $216 million, and a low‑ to mid‑single‑digit adjusted EBITDA margin (with full‑year adjusted EBITDA profitability expected); management also expects global Jeuveau revenue to grow high single‑digits in 2026 and Q2 U.S. Jeuveau net revenue to more than offset the Q1 headwind. First‑quarter results that support the outlook included global net revenue of $73.1 million (+7% YoY), Jeuveau revenue of $66.4 million, Evolisse $6.7 million, reported gross margin 67% (adjusted gross margin 68%), and positive adjusted EBITDA of $0.6 million; the company ended Q1 with $49.8 million cash and access to an additional $120 million in capital.
Revenue Growth and Brand Performance
Q1 global net revenue $73.1M, up 7% year-over-year; Jeuveau contributed $66.4M (positive unit growth and pricing stability) and Evolisse $6.7M. Jeuveau U.S. market share maintained at 14% with expected high single-digit YoY growth over the comparable period.
Profitability Momentum
Second consecutive quarter of positive adjusted EBITDA: Q1 adjusted EBITDA $0.6M vs a loss of $5.5M in the prior-year period (improvement of ~$6.1M), and company reiterates expectation of full-year adjusted EBITDA profitability in 2026.
Healthy Margins
Reported gross margin in Q1 was 67% and adjusted gross margin was 68% (adjusted excludes amortization of intangibles); full-year adjusted gross margin guidance of 65.5%–67% reiterated.
Commercial Reach and Engagement
Total purchasing accounts rose by nearly 500 in Q1; since launch >18,000 customers have purchased, including ~3,500 for Evolisse. U.S. account penetration above 60% and reorder rates ~71%.
Digital Ecosystem and Loyalty Growth
Evolus, Inc. Rewards approaching 1.5M members, up 27% YoY, with >255,000 redemptions in the quarter; company is embedding AI into its unified data platform to drive field productivity and targeted engagement.
Pipeline and International Expansion
Sculp FDA approval expected in Q4 2026 (key mid-face HA product); Esteem launch in Europe mid-May expands addressable market and is expected to support future U.S. launches and portfolio momentum.
Liquidity and Capital Flexibility
Cash and cash equivalents $49.8M at quarter-end, plus access to an additional $120M in capital ($100M term facility and $20M revolver); term loan maturity mid-2030 and modest cash usage (~$3M over prior two quarters).
Guidance and Long‑Term Outlook Reiterated
Full-year 2026 guidance reiterated: total net revenue $327M–$337M, non-GAAP operating expenses $210M–$216M, adjusted gross margin 65.5%–67%, and low- to mid-single-digit adjusted EBITDA margin; long-term double-digit revenue growth and margin expansion through 2028 reiterated.

Evolus (EOLS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

EOLS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Aug 05, 2026
2026 (Q2)
-0.04 / -
-0.247
May 04, 2026
2026 (Q1)
-0.11 / -0.05
-0.14969.13% (+0.10)
Mar 03, 2026
2025 (Q4)
0.04 / 0.04
0.03333.33% (+0.01)
Nov 05, 2025
2025 (Q3)
-0.16 / -0.13
-0.16218.52% (+0.03)
Aug 05, 2025
2025 (Q2)
-0.11 / -0.25
-0.039-533.33% (-0.21)
May 07, 2025
2025 (Q1)
-0.14 / -0.15
-0.083-79.52% (-0.07)
Mar 04, 2025
2024 (Q4)
0.02 / 0.03
-0.124126.61% (+0.16)
Nov 06, 2024
2024 (Q3)
-0.12 / -0.16
-0.1651.82% (<+0.01)
Jul 31, 2024
2024 (Q2)
-0.05 / -0.04
-0.19580.00% (+0.16)
May 07, 2024
2024 (Q1)
-0.15 / -0.08
-0.15145.03% (+0.07)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

EOLS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
May 04, 2026
$5.58$6.37+14.16%
Mar 03, 2026
$4.13$5.59+35.35%
Nov 05, 2025
$6.81$7.18+5.43%
Aug 05, 2025
$8.91$6.37-28.51%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Evolus, Inc. (EOLS) report earnings?
Evolus, Inc. (EOLS) is schdueled to report earning on Aug 05, 2026, Before Open (Confirmed).
    What is Evolus, Inc. (EOLS) earnings time?
    Evolus, Inc. (EOLS) earnings time is at Aug 05, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is EOLS EPS forecast?
          EOLS EPS forecast for the fiscal quarter 2026 (Q2) is -0.04.